Clinicopathological Significance of BRCAness in Resectable Pancreatic Ductal Adenocarcinoma and Its Association With Anticancer Drug Sensitivity in Pancreatic Cancer Cells
Conclusions
Our results revealed that a considerable number of PDACs are positive for BRCAness, suggesting that BRCAness status could be a useful biomarker for selecting anticancer treatments for advanced or relapsed PDAC.
Source: Pancreas - Category: Gastroenterology Tags: Original Articles Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Gastroenterology | Gastroschisis Repair | Genetics | Pancreas | Pancreatic Cancer | Study